ProShares Ultra Nasdaq Biotechnology
(NASDAQ: BIB)
AdChoices
114.18
+3.50
+3.16%
:

Open

111.74

Net Assets

306.58M

Day's Range

110.45-114.87

52 week range

57.30-114.87

Category

Trading-Leveraged Equity

Vol (3-Month Avg.)

240.57k

Yield

0.00%

Morningstar Risk

-

AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Key Statistics
Composition
Equity Investment Style
The two dimensions of the Fund Style box measure the average size of companies that have been in the ETF, from the top to bottom, and the average valuation characteristics of the ETF's past stock holdings, from left to right.

PERFORMANCE

  • Total Return %

  • 1 Day

  • 1 Week

  • 1 Month

  • 3 Months

  • 1 Year

  • 3 Years

  • 5 Years

    • BIB

    • 5.37

    • 17.73

    • 8.03

    • 18.07

    • 71.87

    • 93.76

    • -

    • Category(Trading-Leveraged Equity)

    • 2.14

    • 7.87

    • -6.00

    • -10.46

    • 12.98

    • 30.03

    • 22.64

    • Rank in Category

    • 4

    • 4

    • 4

    • 1

    • 4

    • 1

    • -

    MORNINGSTAR RATING

    • Years

    • Return

    • Risk

    • Rating

      • 3 Years

      • -

      • -

      • -

      • 5 Years

      • -

      • -

      • -

      • 10 Years

      • -

      • -

      • -

      • Overall

      • -

      • -

      • -

      TOP HOLDINGS

      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Nasdaq Biotechnology Index Swap Ubs Ag

        • 55.15

        • 63,078

        • -16,254

        • Ishares Biotech (Ibb) Swap Deutsche Bank Ag

        • 25.99

        • 43,106

        • 7,095

        • Nasdaq Biotechnology Index Swap Credit Suisse International

        • 19.16

        • 21,913

        • -4,004

        • Nasdaq Biotechnology Index Swap Bank Of America, Na

        • 10.33

        • 11,811

        • 517

        • Amgen Inc

        • 5.80

        • 135,104

        • -39,778

        • Celgene Corp

        • 5.74

        • 198,177

        • -66,927

        • Gilead Sciences Inc

        • 5.70

        • 175,040

        • -74,738

        • Biogen Idec Inc

        • 5.55

        • 54,894

        • -8,620

        • Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc

        • 5.48

        • 9,091

        • 4,318

        • Nasdaq Biotechnology Index Swap Deutsche Bank Ag

        • 5.20

        • 5,943

        • -6,323

        CATEGORY

        • Name

        • BIB

        • Category

          • Avg. Market Cap USD (M)

          • -

          • -

          • Expense Ratio

          • 0.95%

          • 0.95%

          • Net Assets

          • 306.58M

          • 215.08M

          • Price/Prospective Earnings

          • 29.59

          • 17.88

          • Price/Book

          • 6.68

          • 2.29

          • Price/Sales

          • 7.22

          • 1.90

          • Price/Cash Flow

          • 16.42

          • 7.25

          • Dividend Yield

          • 0.22%

          • 0.22

          Profile

          Name of Issuer

          ProShares

          Expenses

          0.95%

          The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

          Inception

          4/6/2010